Modern genetic markers of chronic heart failure

Author:

Zimina Yu. D.1,Gorbunova A. M.1,Tolmacheva A. A.1,Bazueva А. S.1,Gerasimenko O. N.1

Affiliation:

1. Novosibirsk State Medical University

Abstract

Due to the rapid spread and large coverage, chronic heart failure (CHF) is reaching the state of a pandemic of the 21st century. Among elderly patients, HF is the main reason for referral to hospital. Half of patients with this pathology die within 5 years after diagnosis. Currently, the diagnosis of CHF is gaining momentum due to the importance of this disease. There are more and more studies and works that prove the high sensitivity of cardiac markers for diagnosing CHF. There are many genes that can participate in the formation of a hereditary predisposition, both independently and through interaction with each other. This literature review was carried out in order to identify genetic markers for diagnosing CHF. The results of studies that can be used to analyze the effect of polymorphism of the genes coding angiotensinogen, angiotensin-converting enzyme, β2-adrenoreceptor, nitric oxide synthase, aldosterone synthase are presented. An in-depth study of molecular genetic markers, as well as determining their significance in the development of heart failure, is an urgent problem of modern medicine, the solution of which will make it possible to carry out effective prevention of cardiovascular complications, optimize treatment and improve the prognosis of patients. Information on the topic from publications based on the PubMed, eLibrary databases was used.

Publisher

The Institute of Internal and Preventive Medicine

Reference31 articles.

1. Поляков Д.С., Фомин И.В., Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т., Артемьева Е.Г. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА–ХСН. Кардиология, 2021; 61 (4): 4–14.

2. Зырянов С.К., Чеберда А.Е., Белоусов Д.Ю. Фармакоэкономический анализ лекарственной терапии хронической сердечной недостаточности у больных с коморбидной патологией. Рациональная фармакотерапия в кардиологии, 2018; 14 (2): 167–175. doi: 10.20996/1819-6446-2018-14-2-167-175

3. Клинические рекомендации Минздрава РФ: Хроническая сердечная недостаточность, 2020.

4. Рекомендации ESC по диагностике и лечению острой и хронической сердечной недостаточности, 2021.

5. Свеклина Т.С., Шустов С.Б., Колюбаева С.Н., Кучмин А.Н., Кондратенко А.А., Козлов В.А. Генетические маркеры хронической сердечной недостаточности с сохраненной фракцией выброса. Соврем. проблемы науки и образования, 2021; 3.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3